COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Hassan Esmaeeli1, Mehdi Ghaderian2, Keyhan Sayadpour Zanjani3
1Cardiology Department, School of Medicine, Gorgan University of Medical Sciences, Gorgan, Iran.
Insights
Children with congenital heart disease (CHD) and COVID-19 face severe risks. Early treatment is crucial for better outcomes in pediatric patients with these combined conditions.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 poses significant risks, particularly to children with underlying conditions.
- Diagnosing COVID-19 in children with congenital heart disease (CHD) presents challenges.
- Differentiating viral effects from pre-existing cardiac conditions is complex for clinicians.
Observation:
- Seven pediatric patients with CHD and COVID-19 were analyzed across three medical centers.
- The cohort included infants and adolescents, with a median age of 9 months.
- All patients had obstructive lesions or pulmonary hypertension; common symptoms included cough, dyspnea, and fever.
Findings:
- Children with CHD, especially those with obstructive lesions or pulmonary hypertension, are vulnerable to severe COVID-19.
- Two out of seven pediatric patients in the case series did not survive.
Implications:
- Urgent treatment is vital for pediatric patients with co-occurring COVID-19 and severe cardiac conditions.
- This highlights the need for heightened vigilance and tailored management strategies.
- Further research is warranted to understand COVID-19's impact on pediatric cardiovascular health.
Background:
Promptly discovering and counteracting COVID-19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID-19 and various types of congenial heart disease among children. Patients and Methods. Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed.
Results:
The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness.
Conclusion:
Prompt treatment of patients with a combination of COVID-19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.
More Related Videos
07:43Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion
Published on: February 22, 2013
14:52Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods
Published on: November 24, 2012
Related Concept Videos
Respiratory Syncytial Virus Disease
Cytomegalovirus Disease
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
